awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34058113-43F45BBF-B2A3-4DD5-9A8B-C94B0815B06B
Q34058113-43F45BBF-B2A3-4DD5-9A8B-C94B0815B06B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34058113-43F45BBF-B2A3-4DD5-9A8B-C94B0815B06B
Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood.
P2860
Q34058113-43F45BBF-B2A3-4DD5-9A8B-C94B0815B06B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34058113-43F45BBF-B2A3-4DD5-9A8B-C94B0815B06B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
09e3ae8e2887b29b8889065d2e60ca41f56b0e07
P2860
Phase II, randomized, double-blind, multicenter study comparing the safety and pharmacokinetics of tefibazumab to placebo for treatment of Staphylococcus aureus bacteremia